Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
about
Parkinson's Disease: From Pathogenesis to PharmacogenomicsSCFFBXO17 E3 ligase modulates inflammation by regulating proteasomal degradation of glycogen synthase kinase-3β in lung epithelia.Ubiquitin and Parkinson's disease through the looking glass of genetics.Mechanistic contributions of FBXO7 to Parkinson disease.
P2860
Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gsk3β and Tomm20 are substrate ...... ated with Parkinson's disease.
@en
Gsk3β and Tomm20 are substrate ...... ated with Parkinson's disease.
@nl
type
label
Gsk3β and Tomm20 are substrate ...... ated with Parkinson's disease.
@en
Gsk3β and Tomm20 are substrate ...... ated with Parkinson's disease.
@nl
prefLabel
Gsk3β and Tomm20 are substrate ...... ated with Parkinson's disease.
@en
Gsk3β and Tomm20 are substrate ...... ated with Parkinson's disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Gsk3β and Tomm20 are substrate ...... iated with Parkinson's disease
@en
P2093
David Komander
Grasilda Zenkeviciute
Shachi P Patel
Suzanne J Randle
P2860
P304
P356
10.1042/BCJ20160387
P407
P577
2016-08-08T00:00:00Z